Daily as of 3 Nov 16:00 ET
- Price
- above both $120.28 vs 50 $110.44 / 200 $79.11
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 24 Jun 2026 · projected 25 bars out
HAE | Haemonetics CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$120.28
+$0.14 (+0.12%)
Haemonetics Corporation (HAE) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $119.65 vs 50 $79.21 / 200 $77.93
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 🟨Golden cross week of 19 Oct 2026 · projected 26 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $121.31 vs 50 $115.49 / 200 $96.25
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Jun 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 19 Oct 2026 | 🟨Golden steep | weekly | 26 bars out | Active Cross Test |
| 24 Jun 2026 | 🟨Golden steep | daily | 25 bars out | Not tested |
| 9 Jun 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 19 Mar 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 18 Feb 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
About HAE
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$62.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmid